Assessment of IL-18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients.
about
Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients.A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease.Evaluation of the Role of -137G/C Single Nucleotide Polymorphism (rs187238) and Gene Expression Levels of the IL-18 in Patients with Coronary Artery Disease.
P2860
Assessment of IL-18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Assessment of IL-18 Serum Leve ...... Artery Disease (CAD) Patients.
@en
Assessment of IL-18 Serum Leve ...... Saudi Coronary Artery Disease
@nl
type
label
Assessment of IL-18 Serum Leve ...... Artery Disease (CAD) Patients.
@en
Assessment of IL-18 Serum Leve ...... Saudi Coronary Artery Disease
@nl
prefLabel
Assessment of IL-18 Serum Leve ...... Artery Disease (CAD) Patients.
@en
Assessment of IL-18 Serum Leve ...... Saudi Coronary Artery Disease
@nl
P2093
P2860
P356
P1476
Assessment of IL-18 Serum Leve ...... Artery Disease (CAD) Patients.
@en
P2093
Absarul Haque
Chelapram K Firoz
Ghazi A Damanhouri
Hussein A Almehdar
Mohammed Nabil Alama
Nasimudeen R Jabir
Qamre Alam
P2860
P304
P356
10.1002/JCB.25870
P577
2017-01-06T00:00:00Z